{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:13:15Z","timestamp":1790341995235,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23194-1","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:22:11Z","timestamp":1748236931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time to reoccurrence of tuberculosis and its predictors among adult HIV\/AIDS patients on ART at public hospitals in East and Horro Guduru Wollega zones, West Ethiopia: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jira Wakoya","family":"Feyisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mebrate","family":"Dufera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikila Regassa","family":"Feyisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidise","family":"Debelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibril","family":"Dori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adisu Tafari","family":"Shama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"23194_CR1","unstructured":"Federal Ministry of Health of Ethiopia (FMOHE). Guideline for clinical and programmatic management of TB, leprosy and TB\/HIV in Ethiopia. FMOH Addis Ababa, Ethiopia 2015. Available athttp:\/\/repository.iifphc.org\/bitstream\/handle\/123456789\/1662\/Guidelines_for_Clinical_and_Programmatic_Management_of_TB_TBHIV.pdf?sequence=1&isAllowed=y. Accessed on 10\/10\/2023."},{"key":"23194_CR2","unstructured":"World Health Organization (WHO). The global plan to stop TB 2011\u20132015: transforming the fight towards elimination of tuberculosis. Available athttps:\/\/www.who.int\/publications-detail-redirect\/9789241500340.Accessed on 10\/10\/2022."},{"key":"23194_CR3","unstructured":"WHO., GlobalTuberculosis Report: World Health Organization;. 2018. Available from: https:\/\/www.who.int\/tb\/publications\/global_report\/en\/.Accessed on 15\/10\/2022."},{"key":"23194_CR4","unstructured":"Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available athttp:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. Accessed on 20\/10\/2022."},{"key":"23194_CR5","doi-asserted-by":"crossref","unstructured":"Dembelu M, Woseneleh T. Prevalence of and factors associated with reoccurrence of opportunistic infections among adult HIV\/AIDS patients attending the ART clinic at public health facilities in Arba minch town, Southern Ethiopia. Volume 13. HIV AIDS (Auckl); 2021. pp. 867\u201376.","DOI":"10.2147\/HIV.S328362"},{"key":"23194_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-319-64371-7_3","volume":"1019","author":"M Merker","year":"2017","unstructured":"Merker M, et al. The evolution of strain typing in the Mycobacterium tuberculosis complex. Adv Exp Med Biol. 2017;1019:43\u201378.","journal-title":"Adv Exp Med Biol"},{"key":"23194_CR7","doi-asserted-by":"crossref","unstructured":"Shanmugam S et al. Whole genome sequencing based differentiation between re-infection and relapse in Indian patients with tuberculosis recurrence, with and without HIV co-infection. Int J Infect Dis, 2021.","DOI":"10.1101\/2020.07.29.227926"},{"issue":"1","key":"23194_CR8","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1186\/s12879-019-4709-5","volume":"19","author":"S Mutembo","year":"2019","unstructured":"Mutembo S, et al. Urban-rural disparities in treatment outcomes among recurrent TB cases in Southern Province, Zambia. BMC Infect Dis. 2019;19(1):1087.","journal-title":"BMC Infect Dis"},{"key":"23194_CR9","unstructured":"WHO., Global Tuberculosis Report. 2017. Available at https:\/\/www.who.int\/publications\/i\/item\/9789241565516. Accessed [10\/10\/2022]."},{"key":"23194_CR10","unstructured":"Patel V et al. Mental, Neurological, and Substance Use Disorders. Disease Control Priorities, third edition, volume 4. Washington, DC: World Bank. doi:10.1596\/978-1-4648-0426-7. License: Creative Commons Attribution CC BY 3.0 IGO. 2015."},{"issue":"9294","key":"23194_CR11","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(01)06712-5","volume":"358","author":"P Sonnenberg","year":"2001","unstructured":"Sonnenberg P, et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358(9294):1687\u201393.","journal-title":"Lancet"},{"issue":"5","key":"23194_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1086\/650528","volume":"201","author":"S Narayanan","year":"2010","unstructured":"Narayanan S, et al. Impact of HIV infection on the recurrence of tuberculosis in South India. J Infect Dis. 2010;201(5):691\u2013703.","journal-title":"J Infect Dis"},{"key":"23194_CR13","unstructured":"WHO. Global Tuberculosis Report 2019. Tuberculosis (TB). Available athttps:\/\/www.who.int\/tb\/publications\/global_report\/en\/.Accessed on 11\/9\/2022."},{"issue":"2","key":"23194_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jiac.2019.08.012","volume":"26","author":"Y Furukawa","year":"2020","unstructured":"Furukawa Y, et al. Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi\u2019s sarcoma and cytomegalovirus retinitis. J Infect Chemother. 2020;26(2):279\u201381.","journal-title":"J Infect Chemother"},{"issue":"3","key":"23194_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2967\/jnumed.119.233783","volume":"61","author":"IO Lawal","year":"2020","unstructured":"Lawal IO, et al. (18)F-FDG PET\/CT as a noninvasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis. J Nucl Med. 2020;61(3):412\u20137.","journal-title":"J Nucl Med"},{"key":"23194_CR16","unstructured":"WHO. Global tuberculosis report 2020. Available athttps:\/\/www.who.int\/tb\/publications\/global_report\/TB20_Exec_Sum_20201014.pdf. Accessed on 4\/8\/2022."},{"issue":"1","key":"23194_CR17","doi-asserted-by":"publisher","first-page":"e0168865","DOI":"10.1371\/journal.pone.0168865","volume":"12","author":"Y Sun","year":"2017","unstructured":"Sun Y, et al. Impact of multidrug resistance on tuberculosis recurrence and Long-Term outcome in China. PLoS ONE. 2017;12(1):e0168865\u20130168865.","journal-title":"PLoS ONE"},{"key":"23194_CR18","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/s12889-015-2327-8","volume":"15","author":"Y Sun","year":"2015","unstructured":"Sun Y, et al. Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China. BMC Public Health. 2015;15:1027.","journal-title":"BMC Public Health"},{"issue":"6","key":"23194_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.5588\/ijtld.11.0210","volume":"16","author":"J McGreevy","year":"2012","unstructured":"McGreevy J, et al. Outcomes of HIV-infected patients treated for recurrent tuberculosis with the standard retreatment regimen. Int J Tuberc Lung Dis. 2012;16(6):841\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"23194_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40257-019-00422-0","volume":"20","author":"K Chelidze","year":"2019","unstructured":"Chelidze K, et al. HIV-Related skin disease in the era of antiretroviral therapy: recognition and management. Am J Clin Dermatol. 2019;20(3):423\u201342.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"23194_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12981-017-0186-3","volume":"14","author":"MF \u00c1lvarez Barreneche","year":"2017","unstructured":"\u00c1lvarez Barreneche MF, et al. Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia. AIDS Res Ther. 2017;14(1):60.","journal-title":"AIDS Res Ther"},{"issue":"3","key":"23194_CR22","first-page":"207","volume":"48","author":"AY Siregar","year":"2016","unstructured":"Siregar AY, Pitriyan P, Wisaksana R. HIV patients drop out in Indonesia: associated factors and potential productivity loss. Acta Med Indones. 2016;48(3):207\u201316.","journal-title":"Acta Med Indones"},{"issue":"8","key":"23194_CR23","first-page":"828","volume":"11","author":"R Panjabi","year":"2007","unstructured":"Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007;11(8):828\u201337.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"23194_CR24","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.4314\/ahs.v19i2.33","volume":"19","author":"G Muzanyi","year":"2019","unstructured":"Muzanyi G, et al. Predictors of recurrent TB in sputum smear and culture positive adults: a prospective cohort study. Afr Health Sci. 2019;19(2):2091\u20139.","journal-title":"Afr Health Sci"},{"issue":"4","key":"23194_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5588\/ijtld.13.0694","volume":"18","author":"Y-F Yen","year":"2014","unstructured":"Yen Y-F, Lin YM-Y, Lin Y-S, Shih Y-P, Li H-C. Smoking increases risk of recurrence after successful anti-tuberculosis treatment: a population- based study. Int J Tuberc Lung Dis. 2014;18(4):492\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"23194_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5588\/ijtld.15.0442","volume":"20","author":"L Kim","year":"2016","unstructured":"Kim L, Heilig MP, Yelk Woodruff CM, Kammerer RS, Haddad JS. Factors associated with recurrent tuberculosis more than 12 months after treatment completion. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2016;20(1):49\u201356.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"11","key":"23194_CR27","doi-asserted-by":"publisher","first-page":"e26541","DOI":"10.1371\/journal.pone.0026541","volume":"6","author":"L Pascopella","year":"2011","unstructured":"Pascopella L, Watt DK, Flood JP. When tuberculosis comes back: who develops recurrent tuberculosis in California? Https\/\/. PLoS One. 2011;6(11):e26541. https:\/\/doi.org\/10.1371\/journal.pone.0026541.","journal-title":"PLoS One"},{"key":"23194_CR28","doi-asserted-by":"publisher","first-page":"p767","DOI":"10.1186\/s12879-019-4401-9","volume":"19","author":"LM Muyaya","year":"2019","unstructured":"Muyaya LM, Musanda EM, Tamuzi JL. Human immune deficiency virus associated tuberculosis care in Botswana: evidence from real world setting. BMC Infect Disease. 2019;19:p767.","journal-title":"BMC Infect Disease"},{"issue":"1","key":"23194_CR29","doi-asserted-by":"publisher","first-page":"e0227291","DOI":"10.1371\/journal.pone.0227291","volume":"15","author":"S Brugueras","year":"2020","unstructured":"Brugueras S, et al. Tuberculosis recurrences and predictive factors in a vulnerable population in Catalonia. PLoS ONE. 2020;15(1):e0227291.","journal-title":"PLoS ONE"},{"key":"23194_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/1471-2458-9-348","volume":"9","author":"DG Datiko","year":"2009","unstructured":"Datiko DG, Lindtj\u00f8rn B. Tuberculosis recurrence in smear-positive patients cured under DOTS in Southern Ethiopia: retrospective cohort study. BMC Public Health. 2009;9:348. https:\/\/doi.org\/10.1186\/1471-2458-9-348.","journal-title":"BMC Public Health"},{"key":"23194_CR31","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1186\/s12889-019-7912-9","volume":"19","author":"B Temesgen","year":"2019","unstructured":"Temesgen B, et al. Incidence and predictors of tuberculosis among HIV-positive adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: a retrospective record review. BMC Public Health. 2019;19:1566. https:\/\/doi.org\/10.1186\/s12889-019-7912-9.","journal-title":"BMC Public Health"},{"key":"23194_CR32","first-page":"145","volume":"2","author":"PO Erah","year":"2008","unstructured":"Erah PO, Arute JE. Adherence of HIV\/AIDS patients to antiretroviral therapy in a tertiary health facility in Benin City. Afr J Pharm Pharmacol. 2008;2:145\u201352. Available online. http:\/\/www.academicjournals.org\/ajpp.","journal-title":"Afr J Pharm Pharmacol"},{"key":"23194_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Ser B (Methodological). 1972;34:187\u2013202. WorldCat.","journal-title":"J R Stat Soc Ser B (Methodological)"},{"issue":"12","key":"23194_CR34","first-page":"1385","volume":"9","author":"LF Lopez-Cortes","year":"2005","unstructured":"Lopez-Cortes LF, et al. Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients. Int J Tuberc Lung Dis. 2005;9(12):1385\u201390.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"23194_CR35","doi-asserted-by":"publisher","first-page":"ofab340","DOI":"10.1093\/ofid\/ofab340","volume":"8","author":"SH Gan","year":"2021","unstructured":"Gan SH, et al. Recurrent tuberculosis disease in Singapore. Open Forum Infect Dis. 2021;8(7):ofab340.","journal-title":"Open Forum Infect Dis"},{"key":"23194_CR36","doi-asserted-by":"publisher","first-page":"638990","DOI":"10.3389\/fcimb.2021.638990","volume":"11","author":"Y Shao","year":"2021","unstructured":"Shao Y, et al. Relapse or Re-Infection, the situation of recurrent tuberculosis in Eastern China. Front Cell Infect Microbiol. 2021;11:638990.","journal-title":"Front Cell Infect Microbiol"},{"key":"23194_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tube.2017.01.007","volume":"103","author":"X Shen","year":"2017","unstructured":"Shen X, et al. Recurrent tuberculosis in an urban area in China: relapse or exogenous reinfection? Tuberculosis (Edinb). 2017;103:97\u2013104.","journal-title":"Tuberculosis (Edinb)"},{"issue":"8","key":"23194_CR38","doi-asserted-by":"publisher","first-page":"871","DOI":"10.5588\/ijtld.17.0766","volume":"22","author":"YF van der Heijden","year":"2018","unstructured":"van der Heijden YF, et al. Older age at first tuberculosis diagnosis is associated with tuberculosis recurrence in HIV-negative persons. Int J Tuberc Lung Dis. 2018;22(8):871\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"23194_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5588\/ijtld.17.0590","volume":"22","author":"A Rosser","year":"2018","unstructured":"Rosser A, Marx FM, Pareek M. Recurrent tuberculosis in the pre-elimination era. Int J Tuberc Lung Dis. 2018;22(2):139\u201350.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"23194_CR40","doi-asserted-by":"publisher","first-page":"e64898","DOI":"10.1371\/journal.pone.0064898","volume":"8","author":"JP Millet","year":"2013","unstructured":"Millet JP, et al. Barcelona tuberculosis recurrence working group. tuberculosis recurrence after completion treatment in a European City: reinfection or relapse? PLoS ONE. 2013;8(6):e64898. https:\/\/doi.org\/10.1371\/journal.pone.0064898. PMID: 23776440; PMCID: PMC3679149.","journal-title":"PLoS ONE"},{"issue":"6","key":"23194_CR41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s15010-015-0759-9","volume":"43","author":"C Schiroli","year":"2015","unstructured":"Schiroli C, et al. Exogenous reinfection of tuberculosis in a low-burden area. Infection. 2015;43(6):647\u201353.","journal-title":"Infection"},{"key":"23194_CR42","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3389\/fmicb.2018.01858","volume":"9","author":"Z Zong","year":"2018","unstructured":"Zong Z, et al. Relapse versus reinfection of recurrent tuberculosis patients in a National tuberculosis specialized hospital in Beijing, China. Front Microbiol. 2018;9:1858.","journal-title":"Front Microbiol"},{"issue":"6","key":"23194_CR43","doi-asserted-by":"publisher","first-page":"e0268290","DOI":"10.1371\/journal.pone.0268290","volume":"17","author":"HM Youn","year":"2022","unstructured":"Youn HM, et al. Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLoS ONE. 2022;17(6):e0268290. https:\/\/doi.org\/10.1371\/journal.pone.0268290.","journal-title":"PLoS ONE"},{"issue":"Suppl 3","key":"23194_CR44","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1093\/infdis\/jiu147","volume":"209","author":"S Nhamoyebonde","year":"2014","unstructured":"Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis. 2014;209(Suppl 3):S100\u2013106.","journal-title":"J Infect Dis"},{"issue":"5","key":"23194_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.5588\/ijtld.17.0194","volume":"21","author":"TA Yates","year":"2017","unstructured":"Yates TA, Atkinson SH. Ironing out sex differences in tuberculosis prevalence. Int J Tuberc Lung Dis. 2017;21(5):483\u20134.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"23194_CR46","doi-asserted-by":"publisher","first-page":"e1002119","DOI":"10.1371\/journal.pmed.1002119","volume":"13","author":"KC Horton","year":"2016","unstructured":"Horton KC, et al. Sex differences in tuberculosis burden and notifications in Low- and Middle-Income countries: A systematic review and Meta-analysis. PLoS Med. 2016;13(9):e1002119.","journal-title":"PLoS Med"},{"issue":"9","key":"23194_CR47","doi-asserted-by":"publisher","first-page":"E331","DOI":"10.1111\/j.1469-0691.2012.03931.x","volume":"18","author":"J-Y Feng","year":"2012","unstructured":"Feng J-Y, et al. Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study. Clin Microbiol Infect. 2012;18(9):E331\u2013337.","journal-title":"Clin Microbiol Infect"},{"key":"23194_CR48","doi-asserted-by":"publisher","first-page":"e10799","DOI":"10.1371\/journal.pone.0010799","volume":"5","author":"GX He","year":"2010","unstructured":"He GX, et al. Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment. PLoS ONE. 2010;5:e10799.","journal-title":"PLoS ONE"},{"key":"23194_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2458-14-88","volume":"14","author":"M Djibuti","year":"2014","unstructured":"Djibuti M, et al. Household income and poor treatment outcome among patients with tuberculosis in Georgia: a cohort study. BMC Public Health. 2014;14:88\u201388. pmid:24476154.","journal-title":"BMC Public Health"},{"key":"23194_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.rppnen.2017.11.003","volume":"24","author":"R Duarte","year":"2018","unstructured":"Duarte R, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology. 2018;24:115\u20139. pmid:29275968.","journal-title":"Pulmonology"},{"key":"23194_CR51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5588\/ijtld.16.0597","volume":"21","author":"M Dias","year":"2017","unstructured":"Dias M, et al. Tuberculosis among the homeless: should we change the strategy? Int J Tuberc Lung Dis. 2017;21:327\u201332.","journal-title":"Int J Tuberc Lung Dis"},{"key":"23194_CR52","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12879-014-0548-6","volume":"14","author":"G Unis","year":"2014","unstructured":"Unis G, et al. Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in Brazil. BMC Infect Dis. 2014;14:548.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"23194_CR53","doi-asserted-by":"publisher","first-page":"550","DOI":"10.5588\/ijtld.16.0651","volume":"21","author":"KD Dale","year":"2017","unstructured":"Dale KD, et al. Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002\u20132014. Int J Tuberc Lung Dis. 2017;21(5):550\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"23194_CR54","doi-asserted-by":"publisher","first-page":"e0144136","DOI":"10.1371\/journal.pone.0144136","volume":"10","author":"JY Wang","year":"2015","unstructured":"Wang JY, et al. Nine- to Twelve-Month Anti-Tuberculosis treatment is associated with a lower recurrence rate than 6-9-Month treatment in human immunodeficiency Virus-Infected patients: A retrospective Population-Based cohort study in Taiwan. PLoS ONE. 2015;10(12):e0144136.","journal-title":"PLoS ONE"},{"key":"23194_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2018.06.013","volume":"74","author":"JRBM Bestrashniy","year":"2018","unstructured":"Bestrashniy JRBM, et al. Recurrence of tuberculosis among patients following treatment completion in eight provinces of Vietnam: A nested case-control study. Int J Infect Dis. 2018;74:31\u20137. Available from: pmid:29944930.","journal-title":"Int J Infect Dis"},{"key":"23194_CR56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fpubh.2019.00182","volume":"7","author":"Q Chen","year":"2019","unstructured":"Chen Q, et al. Recurrence is a noticeable cause of Rifampicin-Resistant Mycobacterium tuberculosis in the elderly population in Jiangxi, China. Front Public Health. 2019;7:182. https:\/\/doi.org\/10.3389\/fpubh.2019.00182.","journal-title":"Front Public Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23194-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23194-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23194-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T07:04:03Z","timestamp":1748243043000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23194-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23194"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23194-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was done in accordance with the Declaration of Helsinki. A letter of ethical clearance was obtained from the institutional research ethics review committee of Wollega University with reference number (IHSRPTTAD\/147\/2023). The ethics committee provided the approval for the waiver of informed consent from the participants as the secondary data were used. Data were collected after explaining to the institutional research ethics review committee that the confidentiality of record review was kept, and no exposition of data at individual level. Permission letter was taken from the East and Horro Guduru Wollega zonal health departments and hospital administrations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1939"}}